PET and MRI Imaging With Scopolamine at the Muscarinic M1 Receptor
Status:
Not yet recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the target occupancy (TO) of scopolamine at M1
Muscarinic Receptors in the brain after single I.V. doses of scopolamine, in healthy control
subjects, using the radiotracer [11C]EMO (also known as [11C]LSN3172176).